I. Meek

1.0k total citations
16 papers, 432 citations indexed

About

I. Meek is a scholar working on Rheumatology, Nephrology and Pathology and Forensic Medicine. According to data from OpenAlex, I. Meek has authored 16 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Rheumatology, 5 papers in Nephrology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in I. Meek's work include Rheumatoid Arthritis Research and Therapies (6 papers), Gout, Hyperuricemia, Uric Acid (5 papers) and Systemic Lupus Erythematosus Research (4 papers). I. Meek is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (6 papers), Gout, Hyperuricemia, Uric Acid (5 papers) and Systemic Lupus Erythematosus Research (4 papers). I. Meek collaborates with scholars based in Netherlands, United States and Sweden. I. Meek's co-authors include Harald E. Vonkeman, Mart A F J van de Laar, Mart AFJ van de Laar, Kris L. L. Movig, Jaap Fransen, Maria W. G. Nijhuis–van der Sanden, C.H.M. van den Ende, Alfons A den Broeder, Betsie G.I. van Gaal and Sandra van Dulmen and has published in prestigious journals such as Annals of the Rheumatic Diseases, Journal of Medical Internet Research and Lara D. Veeken.

In The Last Decade

I. Meek

14 papers receiving 419 citations

Peers

I. Meek

RHEUM

PHARM

CCM

HEMAT

IMMUN

Anil Pareek India

Christopher J. Needs Australia

Marshall Sack United States

Shivani Jaswal India

Chih-Chiang Chien Taiwan

F. W. J. Gribnau Netherlands

Michael Ward Australia

L. Connors United States

Lawrence Goldkind United States

Shaina M. Lynch United States

Anil Pareek India

I. Meek

97 ×0.6

RHEUM

115 ×1.1

PHARM

48 ×0.9

CCM

16 ×0.3

HEMAT

32 ×0.7

IMMUN

Citations per year, relative to I. Meek I. Meek (= 1×) peers Anil Pareek

Countries citing papers authored by I. Meek

Since Specialization

Citations

This map shows the geographic impact of I. Meek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Meek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Meek more than expected).

Fields of papers citing papers by I. Meek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Meek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Meek. The network helps show where I. Meek may publish in the future.

Co-authorship network of co-authors of I. Meek

This figure shows the co-authorship network connecting the top 25 collaborators of I. Meek. A scholar is included among the top collaborators of I. Meek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Meek. I. Meek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Verhoef, Lise M, Alfons A den Broeder, Wing‐Yee Kwok, et al.. (2022). Effect of metformin use on clinical outcomes and serum urate in gout patients with diabetes mellitus: a retrospective cohort study. BMC Rheumatology. 6(1). 27–27. 4 indexed citations

Kievit, Wietske, Robert Landewé, I. Meek, et al.. (2022). The added value of predictive biomarkers in treat-to-target strategies for rheumatoid arthritis patients: a conceptual modelling study. Lara D. Veeken. 62(8). 2700–2706. 2 indexed citations

Rennings, Alexander J., Elke Arts, I. Meek, et al.. (2021). Younger age and female gender are determinants of underestimated cardiovascular risk in rheumatoid arthritis patients: a prospective cohort study. Arthritis Research & Therapy. 23(1). 2–2. 12 indexed citations

Broeder, Nathan den, Noortje van Herwaarden, I. Meek, et al.. (2020). Therapeutic drug monitoring of adalimumab in RA: no predictive value of adalimumab serum levels and anti-adalimumab antibodies for prediction of response to the next bDMARD. Annals of the Rheumatic Diseases. 79(7). 867–873. 13 indexed citations

Verhoef, Lise M, Alfons A den Broeder, Wing‐Yee Kwok, et al.. (2020). THU0448 NO DIFFERENCE IN GOUT FLARES AFTER INITIATION OF URATE LOWERING THERAPY BETWEEN ONCE OR TWICE DAILY 0.5 MG COLCHICINE PROPHYLAXIS. Annals of the Rheumatic Diseases. 79. 461–461.

Verhoef, Lise M, Alfons A den Broeder, Wing‐Yee Kwok, et al.. (2020). THU0412 EFFECT OF METFORMIN ON CLINICAL GOUT OUTCOMES IN GOUT PATIENTS WITH DIABETES MELLITUS. Annals of the Rheumatic Diseases. 79. 443–444.

Dulmen, Sandra van, Maria W. G. Nijhuis–van der Sanden, I. Meek, et al.. (2018). Efficacy of a Web-Based Self-Management Enhancing Program for Patients with Rheumatoid Arthritis: Explorative Randomized Controlled Trial. Journal of Medical Internet Research. 21(4). e12463–e12463. 33 indexed citations

Vonkeman, Harald E., Peter M. ten Klooster, Janneke Tekstra, et al.. (2016). Stopping Tumor Necrosis Factor Inhibitor Treatment in Patients With Established Rheumatoid Arthritis in Remission or With Stable Low Disease Activity: A Pragmatic Multicenter, Open‐Label Randomized Controlled Trial. Arthritis & Rheumatology. 68(8). 1810–1817. 66 indexed citations

Hulscher, Marlies, et al.. (2015). Choosing Wisely in Daily Practice: An Intervention Study on Antinuclear Antibody Testing by Rheumatologists. Arthritis Care & Research. 68(4). 562–569. 14 indexed citations

10.

Meek, I., Harald E. Vonkeman, & Mart AFJ van de Laar. (2014). Hyperuricaemia: a marker of increased cardiovascular risk in rheumatic patients: analysis of the ACT-CVD cohort. BMC Musculoskeletal Disorders. 15(1). 174–174. 10 indexed citations

11.

Meek, I., Harald E. Vonkeman, & Mart AFJ van de Laar. (2014). Cardiovascular case fatality in rheumatoid arthritis is decreasing; first prospective analysis of a current low disease activity rheumatoid arthritis cohort and review of the literature. BMC Musculoskeletal Disorders. 15(1). 142–142. 24 indexed citations

12.

Meek, I., et al.. (2014). [Systemic sclerosis: a multisystem disease].. PubMed. 158. A7703–A7703. 1 indexed citations

13.

Meek, I., et al.. (2012). Interference of NSAIDs with the thrombocyte inhibitory effect of aspirin: A placebo-controlled, ex vivo, serial placebo-controlled serial crossover study. European Journal of Clinical Pharmacology. 69(3). 365–371. 43 indexed citations

14.

Meek, I., H. Susan J. Picavet, Harald E. Vonkeman, W. M. Monique Verschuren, & M.A.F.J. van de Laar. (2012). Increased cardiovascular risk factors in different rheumatic diseases compared with the general population. Lara D. Veeken. 52(1). 210–216. 22 indexed citations

15.

Meek, I., et al.. (2011). Acute left ventricular failure in a patient with hydroxychloroquine-induced cardiomyopathy. Netherlands Heart Journal. 19(11). 482–485. 10 indexed citations

16.

Meek, I., Mart A F J van de Laar, & Harald E. Vonkeman. (2010). Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks. Pharmaceuticals. 3(7). 2146–2162. 178 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact